Prognostic value of CA15-3, CA125, CEA in breast cancer patients undergoing chemotherapy

CA15-3、CA125、CEA在接受化疗的乳腺癌患者中的预后价值

阅读:3

Abstract

BACKGROUND: To explore the prognostic value of cancer antigen 15-3 (CA15-3), Carbohydrate antigen 125 (CA125), and carcino-embryonic antigen (CEA) in breast cancer patients undergoing chemotherapy. METHODS: The data of 100 patients with breast cancer who received chemotherapy in a hospital from May 2022 to May 2024 were selected. Patients were divided into control and test groups based on different intervention methods and hospital stays. The control group receives routine nursing interventions. The test group implements exercise intervention under planned behaviour planning, with 50 cases in each group. Patients' exercise cognitive score, cancer-related fatigue, and serum tumour marker levels are compared before, 2 weeks, and 4 weeks of intervention. RESULTS: Before the intervention, there was no difference in exercise cognition scores, cancer-related fatigue (CFS) scores, or serum tumour marker levels (P>0.05). After 2 and 4 weeks of intervention, the exercise attitude, exercise values, exercise behaviour control, and exercise motivation in the test group exceeded the control group (P<0.05). The behavioural, sensory, emotional, and cognitive fatigue scores in the test group were below the control group (P<0.05). The CA15-3, CA125, and CEA in the test group were below the control group (P<0.05). CONCLUSIONS: Exercise intervention under planned behaviour planning is conducive to improving the cognition of breast cancer chemotherapy patients on exercise knowledge, alleviating body fatigue, and reducing the serum markers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。